Clinical Trials Directory

Trials / Unknown

UnknownNCT05000229

Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population

Residual Symptoms in Patients With a History of Coronavirus Disease (COVID-19) and Their Impact on Biopsychosocial Functions (Post-Covid Syndrome)

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Lithuanian University of Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to describe the post-covid-19 syndrome in Lithuanian population regarding the remaining symptoms and their impact on physical functioning, work ability and needs of rehabilitation.

Detailed description

Participants with suspected and confirmed cases of COVID-19 infection will complete an anonymous online questionnaire for post-covid syndrome, i.e. symptoms lasting longer than 28 days after post-covid-19 syndrome. The online survey is developed to assess the health state before infection and residual symptoms lasting longer than acute COVID-19 infection, influencing the functional activity and work ability. The needs of rehabilitation will also be assessed.

Conditions

Timeline

Start date
2021-05-04
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2021-08-11
Last updated
2021-08-11

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT05000229. Inclusion in this directory is not an endorsement.

Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population (NCT05000229) · Clinical Trials Directory